Showing 1 - 4 results of 4 for search 'Katia Abarca', query time: 0.02s Refine Results
  1. 1
    Prevalence and risk factors for echinococcal infection in a rural area of northern Chile: a household-based cross-sectional study.

    Prevalence and risk factors for echinococcal infection in a rural area of northern Chile: a household-based cross-sectional study. by Gerardo Acosta-Jamett, Thomas Weitzel, Belgees Boufana, Claudia Adones, Andrea Bahamonde, Katia Abarca, Philip S Craig, Ingrid Reiter-Owona

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Identification of trombiculid mites (Acari: Trombiculidae) on rodents from Chiloé Island and molecular evidence of infection with Orientia species.

    Identification of trombiculid mites (Acari: Trombiculidae) on rodents from Chiloé Island and molecular evidence of infection with Orientia species. by Gerardo Acosta-Jamett, Constanza Martínez-Valdebenito, Esperanza Beltrami, María Carolina Silva-de La Fuente, Ju Jiang, Allen L Richards, Thomas Weitzel, Katia Abarca

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Eco-epidemiology of rodent-associated trombiculid mites and infection with Orientia spp. in Southern Chile.

    Eco-epidemiology of rodent-associated trombiculid mites and infection with Orientia spp. in Southern Chile. by María Carolina Silva de la Fuente, Caricia Pérez, Constanza Martínez-Valdebenito, Ruth Pérez, Cecilia Vial, Alexandr Stekolnikov, Katia Abarca, Thomas Weitzel, Gerardo Acosta-Jamett

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

    Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccin... by Laura L. Hammitt, Dean Quinn, Ewa Janczewska, Francisco J. Pasquel, Richard Tytus, K. Rajender Reddy, Katia Abarca, Ilsiyar M. Khaertynova, Ron Dagan, Rachel Dawson, Jennifer McCauley, Tulin Shekar, Wei Fu, Alison Pedley, Tina Sterling, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: